soʞnoʞ@ retweeted
Το μεγαλύτερο έγκλημα της Δύσης είναι η ανοχή της σε αυτούς που θέλουν να την καταστρέψουν.
Replying to @zacbowden
Linux is here. Building is easy now, new apps are gonna come. We need one solid distro which is full fledged and clean
soʞnoʞ@ retweeted
Καμιά 200αριά τύποι πήγαν να χειροκροτήσουν την αποφυλάκιση ενός μέλους εγκληματικής οργάνωσης. Ας το κάνουμε πρώτη είδηση σα να μαζεύτηκαν χιλιάδες να του δώσουμε αέρα στα πανιά του ωστε μετά να πάρουμε αντιφασιστικά πιστοποιητικά κλαψουρίζοντας για την άνοδο του ναζισμού.
soʞnoʞ@ retweeted
A butterfly successfully hatched aboard China's Tiangong space station without any human assistance or special radiation shielding.
The insect emerged from its chrysalis inside a small sealed capsule that functioned as a miniature ecosystem. The capsule reached the station aboard a Kuaizhou cargo mission in December. It contained plants microorganisms and sufficient environmental controls to support the butterfly through its full metamorphosis.
The chamber maintained a temperature of about 86 degrees Fahrenheit or 30 degrees Celsius. After hatching the butterfly lived for several days in orbit. It moved around normally even in the absence of gravity.
This outcome is notable because butterflies rely on orientation balance and coordinated movement for flight. Scientists were uncertain how the insect would navigate or behave in microgravity after emerging. Previous space missions including one on the International Space Station in 2009 had seen butterflies complete metamorphosis. This Chinese experiment however operated with far fewer supports.
The capsule lacked radiation shielding full spectrum lighting advanced temperature controls and any ongoing human care once in orbit. The butterfly had to manage inside a compact self contained habitat.
The experiment raises broader questions about whether small ecosystems can operate independently away from Earth. As humans plan longer space missions and potential space agriculture insects may play key roles in pollination and maintaining natural cycles. Understanding how such miniature systems function in orbit could inform the design of future space farms.
soʞnoʞ@ retweeted
Replying to @TheHackersNews
I'm waiting to hear about LUKS getting broke. The computer age is getting ready to go back to local face to face cash.
soʞnoʞ@ retweeted
CNN's Richard Quest reacts to top economic officials in the Trump administration defending the widespread tariffs President Donald Trump announced that caused tumult in the US stock market.
soʞnoʞ@ retweeted
🇬🇧 UK mass arrests citizens for memes
🇫🇷 France arrests founder of Telegram
🇮🇪 Ireland tries to ban "mean memes"
🇧🇷 Brazil forces 𝕏 to flee the country
🇦🇺 Australia tries to censor 𝕏 posts
🇪🇺 EU tries to blackmail Elon Musk
🇺🇸 DOJ jails someone for a meme
🇻🇪 Maduro blocks all access to 𝕏
Free speech is under attack all across the globe. Now is the time to fight.
If they win, there's no going back.
soʞnoʞ@ retweeted
POV: It’s 2030 in Europe and you’re being executed for liking a meme
soʞnoʞ@ retweeted
Oiga Korbut, «Το σπουργίτι του Μινσκ», ερμηνεύει το μυθικό «Loop of Death» σε ηλικία 15 ετών στους Ολυμπιακούς Αγώνες του Μονάχου (1972). Αυτός ο πολύπλοκος ελιγμός απαγορεύτηκε και δεν έχει πραγματοποιηθεί ποτέ ξανά, λόγω του υψηλού επιπέδου κινδύνου.
soʞnoʞ@ retweeted
Having a smart friend
nitter.gq/epiccontentX/status/18…
soʞnoʞ@ retweeted
Η Ιταλίδα αθλήτρια αρνήθηκε να συνεχίσει...
Κατάλαβε ότι δεν μπορεί να τα βγάλει πέρα με αντίπαλο,πρωην άντρα.
Έχουμε παραδοθεί στη woke κουλτούρα, το πνεύμα των Ολυμπιακών αγώνων πέθανε σήμερα!!!
soʞnoʞ@ retweeted
Could any picture sum up our new men’s rights movement better? The smirk of a male who’s knows he’s protected by a misogynist sporting establishment enjoying the distress of a woman he’s just punched in the head, and whose life’s ambition he’s just shattered. #Paris2024
soʞnoʞ@ retweeted
Seems like a good time to re-post my older (now edited) post about athletes with XY DSDs (Disorder, or Difference of Sex Development). Lots of graphs and detail about the relevant biology at the end.
* * *
First: People living with DSDs should be treated with compassion and understanding, and receive any heath care they need. These can be challenging conditions for individuals and their families. But when male athletes have DSDs that give them an advantage over females, and they compete in the female category, this raises concerns about safety and fairness, and forces discussion of the relevant physical traits.
Athletes with XY DSDs who have testes (usually internal), XY sex chromosomes, male-typical levels of testosterone, and functional androgen receptors are often described as females with "hyperandrogenism," i.e., abnormally high levels of testosterone. They experience physical benefits of this high testosterone during puberty, which translate into athletic advantages over females. The issue for sports is that athletes with the XY DSD 5-alpha reductase deficiency (5-ARD), may be socialized as female, may be legally female, and may live and identify as female; but they are male.
These individuals are usually born with female-appearing genitalia, which can lead to being sexed as female. Here's why. 5-ARD is caused by a mutation in the gene that codes for the enzyme 5-alpha reductase, which converts testosterone into a more potent androgen, DHT. This androgen interacts with the androgen receptor, like testosterone, and is necessary for the typical development of male external genitalia (penis and scrotum) and the prostate. Without DHT, female-typical external genitalia develop. At the end of this monster post is a graphic of the relevant steroid production pathway, from my book T: The story of Testosterone.
DHT is also responsible for male-pattern baldness and dark, coarse facial hair, which is why people with the condition have smooth skin that can give a feminine appearance.
The “decision makers” are aware that athletes with 5-ARD are male, and that they experience the benefits of male puberty. The requirement to reduce their testosterone to typical female levels isn’t discriminatory, since these are males who are asking to compete in the female category. But more significantly, all the relevant scientific evidence shows that reducing male T in adulthood does not undo the physical benefits of male puberty.
Here's more detail about T, DHT, and male advantage in strength and speed.
I've been asked if men with the DSD 5-ARD (in which ppl cannot convert testosterone into the more potent androgen DHT) experience the typical benefits of male puberty, that would give them an advantage in strength and speed relative to women. This is relevant to questions about whether male athletes with 5-ARD should be allowed to compete in the female category. This is an excellent question, because it could be the case that DHT is necessary for the development and maintenance of male-typical muscle, lean body mass and strength. If that were the case, then people with 5-ARD might not have a typical male advantage, because the lack of DHT would perhaps lead to a more feminine pattern of fat, lean body mass and strength. I've wondered about this myself and have looked into the evidence.
Perhaps the top researcher in this area, Shalendar Bhasin, who is scrupulous in his methods, has examined this very question. The answer appears to be: no, testosterone does not need to be converted to DHT to exert its typical anabolic effects. These findings are reported in his 2012 study, "Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production, A Randomized Controlled Trial." (It is linked to below—and since it's paywalled, I've included the graphs that show comparisons between the placebo and DHT— inhibited conditions, with no difference on the various outcomes.)
For more detail, the investigators wanted to examine the effects of suppressing DHT on muscle mass, strength, and sexual function. This important because one of the treatments for benign prostatic hyperplasia and male-pattern baldness is to suppress DHT, but clinicians have been concerned about effects on other outcomes that affect health and quality of life. Participants (healthy men, 18 to 50, with normal T levels) had their T blocked, and were given graded doses of T, along with either placebo or a drug that blocked the conversion of T to DHT. So both groups had T, but only one, the placebo group, also had DHT. After 20 weeks of treatment, changes in lean body mass, muscle, and strength were assessed. There were no significant difference between the placebo and DHT-blocked groups in these outcomes.
For LOTS more detail, here's the relevant text from the results. Please don't ask me questions about the study. Just look at the abstract and results which you can find by Googling. The main point is that while there are predicted effects of the different doses of T received, there were no differences in the outcomes according to whether they had DHT blocked (with dutasteride) or not (placebo). "Fat-Free Mass Fat-free mass and lean body mass increased in a dose-dependent manner in the placebo and dutasteride [THIS IS THE DRUG THAT BLOCKS CONVERSION OF T TO DHT] groups (Figure 2).
The changes in fat-free mass were related to testosterone dose and changes in testosterone concentrations in the placebo and dutasteride groups but did not differ between groups; the dose-adjusted mean difference (placebo minus dutasteride) in fat-free mass was 0.50 kg (95% CI, −0.22 to 1.22 kg; P = .18). There was no significant interaction between testosterone dose and randomization to dutasteride or placebo, indicating a lack of evidence that the relationship of testosterone dose to change in fat-free mass differed between the dutasteride and placebo groups.
The model-based smoothed regression lines, obtained by generalized additive models, describing the relationship between changes in testosterone concentrations and changes in fat-free mass and lean body mass were similar in the placebo and dutasteride groups. Changes in fat mass were negatively related to testosterone dose and concentrations, but the relationship between change in fat mass and dose did not differ significantly between the placebo and dutasteride groups (P = .41; Figure 2)."
"Muscle strength Leg-press and chest-press strength increased dependently by dose in the placebo and dutasteride groups. Increases in leg-press and chest-press strength were greater with larger doses and higher concentrations of testosterone. These relationships did not differ between the placebo and dutasteride groups (Figure 2)."
Really interesting commentary from the authors on the role of DHT in adult men: "Why then did the steroid 5α-reductase system evolve for androgens? Forty-six XY males with steroid 5α-reductase deficiency exhibited ambiguous or female external genitalia at birth and poor prostate development, but underwent normal muscle and bone development during pubertal transition. The phenotype of these patients suggests that steroid 5α-reductase plays an essential role in the development of prostate and phallus by providing local amplification of an androgenic signal without systemic hyperandrogenemia during critical periods of sexual differentiation, illustrating nature's extraordinary ingenuity in creating mechanisms for tissue-selective amplification during development.
We speculate that in adult men, in whom this tissue-specific amplification is not essential because the circulating testosterone concentrations are substantially higher than those in the fetus, testosterone and DHT can interchangeably subserve many androgenic functions. When circulating testosterone concentrations are low, intraprostatic DHT formation may become important in maintaining prostate growth, thus buffering the effects of decreasing testosterone levels, which has been suggested by Marks et al.
Our data are consistent with studies that have reported no effects of 5α-reductase inhibitors on muscle or bone mass. Inferences from these trials are limited by the fact that administration of 5α-reductase inhibitors increases testosterone levels, rendering it difficult to ascribe the outcomes to differences in DHT levels alone. In our trial, inhibition of endogenous testosterone by administration of a gonadotropin-releasing hormone agonist eliminated this problem. Additionally, the high-dose dutasteride regimen effectively inhibited both steroid 5α-reductase isoenzymes."
soʞnoʞ@ retweeted
Ήταν θέμα χρόνου η συμπεριληπτική παράνοια να συμπεριλάβει στην ζεστή αγκαλιά της και την κακοποίηση γυναικών από άνδρες.



























